Literature DB >> 2199968

Glucagon and the glucagon-like peptides.

D J Drucker1.   

Abstract

Glucagon and the glucagon-like peptides are encoded within a larger precursor, proglucagon. The proglucagon gene is expressed in the pancreas, intestine, and brain, giving rise to a single proglucagon mRNA transcript that is identical in all tissues. Tissue-specific posttranslational processing of proglucagon accounts for the different molecular forms of the glucagon-related peptides present in each tissue. Glucagon-like peptide I has been demonstrated to have potent insulinotropic properties, but the biological importance of other glucagon-related peptides remains unclear. The recent advances that have increased our understanding of the biology of glucagon and the glucagon-like peptides are reviewed.

Mesh:

Substances:

Year:  1990        PMID: 2199968     DOI: 10.1097/00006676-199007000-00018

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  14 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

3.  Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.

Authors:  D A D'Alessio; R Vogel; R Prigeon; E Laschansky; D Koerker; J Eng; J W Ensinck
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 4.  Is the GLP-1 system a viable therapeutic target for weight reduction?

Authors:  Jenny Tong; Darleen A Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

5.  Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.

Authors:  Kirk M Habegger
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

6.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress.

Authors:  Miyuki Tauchi; Rong Zhang; David A D'Alessio; Randy J Seeley; James P Herman
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

Review 8.  CNS GLP-1 regulation of peripheral glucose homeostasis.

Authors:  Darleen Sandoval
Journal:  Physiol Behav       Date:  2008-05-27

9.  Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei.

Authors:  Miyuki Tauchi; Rong Zhang; David A D'Alessio; Javier E Stern; James P Herman
Journal:  J Chem Neuroanat       Date:  2008-08-19       Impact factor: 3.052

10.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.